Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-28 @ 3:52 PM
Study NCT ID:
NCT00610935
Status:
TERMINATED
Last Update Posted:
2021-03-17
First Post:
2008-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
Sponsor:
BioCryst Pharmaceuticals
Organization:
Study Overview
Official Title:
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.
Status:
TERMINATED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study was terminated for administrative reasons.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety and effectivess of a single intramuscular injection of peramivir for the treatment of subjects with acute, uncomplicated influenza.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| HHS # O100200700032C | REGISTRY | U.S. Department of Health & Human Services | View |